S
Shih-Hung Tsai
Researcher at National Defense Medical Center
Publications - 189
Citations - 2017
Shih-Hung Tsai is an academic researcher from National Defense Medical Center. The author has contributed to research in topics: Retrospective cohort study & Internal medicine. The author has an hindex of 20, co-authored 176 publications receiving 1515 citations. Previous affiliations of Shih-Hung Tsai include Tri-Service General Hospital.
Papers
More filters
Journal ArticleDOI
Interpretation and Use of Natriuretic Peptides in Non-Congestive Heart Failure Settings
TL;DR: Clinicians should recognize that currently the only reasonable application for routine practice is limited to differentiation of acute dyspnea, rule-out-diagnostic-tests, monitoring of therapeutic responses and prognosis of acute or decompensated CHF.
Journal ArticleDOI
Usefulness of Glycemic Gap to Predict ICU Mortality in Critically Ill Patients With Diabetes
TL;DR: The addition of the glycemic gap to the APACHE-II score significantly improved its ability to predict ICU mortality and was used to assess the severity and prognosis of critically ill patients with diabetes.
Journal ArticleDOI
Inhibition of hypoxia inducible factor-1α attenuates abdominal aortic aneurysm progression through the down-regulation of matrix metalloproteinases.
Shih-Hung Tsai,Po Hsun Huang,Yu Juei Hsu,Yi-Jen Peng,Chien Hsing Lee,Jen Chun Wang,Jen Chun Wang,Jaw Wen Chen,Shing Jong Lin +8 more
TL;DR: This study provides a rationale for using HIF-1α inhibitors as an adjunctive medical therapy in addition to current cardiovascular risk-reducing regimens after initial in vitro experiments found that DFO augmented the severity of AngII-induced AAA.
Journal ArticleDOI
Association between use of oral-antidiabetic drugs and the risk of aortic aneurysm: A nested case-control analysis
Chien Yi Hsu,Yu Wen Su,Yu Wen Su,Yung Tai Chen,Shih-Hung Tsai,Chun Chin Chang,Chun Chin Chang,Szu Yuan Li,Szu Yuan Li,Po Hsun Huang,Po Hsun Huang,Jaw Wen Chen,Jaw Wen Chen,Shing Jong Lin +13 more
TL;DR: Metformin, sulfonylurea, and TZD treated patients were associated with lower risks of AA development, but not DPP-4 inhibitors or alpha-glucosidase inhibitor, and the protective effects of hypoglycemic agents are confirmed.
Journal ArticleDOI
Acute renal infarction: a 10‐year experience
TL;DR: Evaluated clinical presentations, laboratory findings, underlying medical conditions and treatment of 18 Chinese patients with ARI who presented to the emergency department of a tertiary teaching hospital from 1995 to 2004, finding decreased effective renal plasma flow in affected kidneys was found in three of three patients.